Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
Parkinson’s disease (PD) is characterized by dopaminergic (DA) neuron death in the substantia nigra (SN) and subsequent striatal adaptations. Mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine (MPTP) are widely used as a model for PD. To assess the validity of the MPTP m...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer US
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789200/ |